rdf:type |
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0013216,
umls-concept:C0024881,
umls-concept:C0030705,
umls-concept:C0332293,
umls-concept:C0439234,
umls-concept:C0580836,
umls-concept:C0600558,
umls-concept:C1280500,
umls-concept:C1306673,
umls-concept:C1522449
|
pubmed:issue |
5
|
pubmed:dateCreated |
2007-11-23
|
pubmed:abstractText |
Postmastectomy radiotherapy (PMRT) improves locoregional control (LRC) in patients with high-risk features after mastectomy. Young age continues to evolve as a potentially important risk factor. The objective of this study was to assess the benefits of PMRT in patients <35 years old treated with doxorubicin-based neoadjuvant chemotherapy for Stage II-III breast cancer.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0360-3016
|
pubmed:author |
pubmed-author:BuchholzThomas ATA,
pubmed-author:GargAmit KAK,
pubmed-author:HahnKarinK,
pubmed-author:HuangEugeneE,
pubmed-author:Meric-BernstamFundaF,
pubmed-author:OhJulia LJL,
pubmed-author:OswaldMary JaneMJ,
pubmed-author:PerkinsGeorge HGH,
pubmed-author:StromEric AEA,
pubmed-author:TereffeWelelaW,
pubmed-author:WoodwardWendy AWA,
pubmed-author:YuT KuanTK
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1478-83
|
pubmed:dateRevised |
2011-6-6
|
pubmed:meshHeading |
pubmed-meshheading:17855016-Adult,
pubmed-meshheading:17855016-Age Factors,
pubmed-meshheading:17855016-Breast Neoplasms,
pubmed-meshheading:17855016-Chemotherapy, Adjuvant,
pubmed-meshheading:17855016-Doxorubicin,
pubmed-meshheading:17855016-Female,
pubmed-meshheading:17855016-Humans,
pubmed-meshheading:17855016-Lymphatic Metastasis,
pubmed-meshheading:17855016-Mastectomy,
pubmed-meshheading:17855016-Neoadjuvant Therapy,
pubmed-meshheading:17855016-Neoplasm Recurrence, Local,
pubmed-meshheading:17855016-Neoplasm Staging,
pubmed-meshheading:17855016-Retrospective Studies,
pubmed-meshheading:17855016-Survival Analysis
|
pubmed:year |
2007
|
pubmed:articleTitle |
Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.
|
pubmed:affiliation |
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
|
pubmed:publicationType |
Journal Article
|